Rob Dillard

DocwireNews

Researchers of a new study have identified a novel protein that plays in a chief role in <a href="https://www.docwirenews.com/docwire-pick/rheumatology-picks/biomarkers-for-distinguishing-rheumatoid-arthritis-from-osteoarthritis/">rheumatoid arthritis</a> (RA). The protein, called sulfatase-2, drives inflammation in RA. The findings were published in Cellular &amp; Molecular Immunology.&nbsp;Sulfatases have been previously studied for their role in cancer, but the protein&rsquo;s role in inflammatory diseases like RA is less understood. The investigators analyzed the concept of using called synovial fibroblasts, which line the joints and keep them lubricated to ensure fluid movement. According to the study, they used the joint-lining cells of rheumatoid arthritis patients to remove sulfatase-2 from one group of cells before stimulating all cells with TNF-alpha.&ldquo;Tumor necrosis factor-alpha&mdash;or TNF-alpha for short&mdash;is one of the main inflammatory proteins that drive rheumatoid arthritis and is targeted by many currently available therapies,&rdquo; said senior author Salah-Uddin Ahmed, a professor in Washington State University&rsquo;s College of Pharmacy and Pharmaceutical Sciences via a <a href="https://www.eurekalert.org/news-releases/964065">press release</a>. &ldquo;However, over time patients can develop a resistance to these drugs, meaning they no longer work for them. That is why we were looking for previously undiscovered drug targets in TNF-alpha signaling, so basically proteins that it interacts with that may play a role.&rdquo;&ldquo;Looking at sulfatases for their potential role in inflammation was an educated guess, but once we did we saw a very consistent pattern of increased sulfatase-2 expression throughout different tissues and samples we studied,&rdquo; Ahmed said. &ldquo;This tells us that TNF-alpha relies on sulfatase-2 to drive inflammation, because as soon as we removed sulfatase-2 the inflammatory effects of TNF-alpha were markedly reduced.&rdquo;The findings of this study could potentially lead to the development of novel therapies that inhibiting sulfatase-2 to ameliorate RA symptoms. &ldquo;These drugs shut off TNF-alpha in your whole body, but it does have important immune functions.&rdquo;&nbsp;

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Latest News

Study Finds Novel Protein Response for Rheumatoid Arthritis Damage

Rheumatology

Researchers of a new study have identified a novel protein that plays in a chief role in rheumatoid arthritis (RA). The protein, called sulfatase-2, drives inflammation in RA. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe